Skip to main content

Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model

Translational Stroke Research volume 7, pages 322–330 (2016)Cite this article

Abstract

Cell-based therapies including bone-marrow derived mononuclear cells (MNCs) are now widely being studied because of their pleotropic effects and promising results to improve recovery after stroke in animal models. Unlike other types of cell therapies, MNCs is a mixture of lymphoid, myeloid, erythroid, and stem cell populations. Which cell population(s) accounts for the beneficial effects of MNCs in stroke recovery is unclear. In this paper, we employed a mouse stroke model with middle cerebral artery occlusion (MCAo), and used positively and negatively sorted autologous MNCs by MACs to determine which fractions of the MNCs contribute to their beneficial effects. We evaluated the benefits of neurofunctional recovery produced by individual cell lineages within MNCs in a long-term observation study up to 28 days after stroke. Mortality and modulation of inflammation were also compared among different sub-populations. We further studied the impact of neurotoxicity posed by activated microglia in the presence of different cell lineages within MNCs. We concluded that myeloid cell lineage and stem cell/progenitors appeared to be important components within MNCs that contribute to improved outcomes after stroke.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 2012;32(7):1310–6.

    Article  Google Scholar 

  2. Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004;1007(1-2):1–9.

    CAS  Article  PubMed  Google Scholar 

  3. Kamiya N, Ueda M, Igarashi H, Nishiyama Y, Suda S, Inaba T, et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 2008;83(11-12):433–7.

    CAS  Article  PubMed  Google Scholar 

  4. Giraldi-Guimardes A, Rezende-Lima M, Bruno FP, Mendez-Otero R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 2009;1266:108–20.

    Article  PubMed  Google Scholar 

  5. Brenneman M, Sharma S, Harting M, Strong R, Cox Jr CS, Aronowski J, et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab. 2010;30(1):140–9.

    Article  Google Scholar 

  6. Mendonca ML, Freitas GR, Silva SA, Manfrim A, Falcao CH, Gonzales C, et al. Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke. Arq Bras Cardiol. 2006;86(1):52–5.

    Article  PubMed  Google Scholar 

  7. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, Goldenberg RC, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med. 2011;6(1):45–52.

    CAS  Article  PubMed  Google Scholar 

  8. Rosado-de-Castro PH, Schmidt Fda R, Battistella V, Lopes de Souza SA, Gutfilen B, Goldenberg RC, et al. Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen Med. 2013;8(2):145–55.

    CAS  Article  PubMed  Google Scholar 

  9. Prasad K, Mohanty S, Bhatia R, Srivastava MV, Garg A, Srivastava A, et al. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian J Med Res. 2012;136(2):221–8.

    PubMed  PubMed Central  Google Scholar 

  10. Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke J Cereb Circ. 2014;45(12):3618–24.

    CAS  Article  Google Scholar 

  11. Savitz SI, Misra V, Kasam M, Juneja H, Cox Jr CS, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70(1):59–69.

    Article  PubMed  Google Scholar 

  12. Yang B, Strong R, Sharma S, Brenneman M, Mallikarjunarao K, Xi X, et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res. 2011;89(6):833–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. Floden AM, Combs CK. Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J Neurosci. 2006;26(17):4644–8.

    CAS  Article  PubMed  Google Scholar 

  14. Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N, et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol. 2007;61(4):352–62.

    CAS  Article  PubMed  Google Scholar 

  15. Yang B, Xi X, Aronowski J, Savitz SI. Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke. Stem Cells Dev. 2012;21(18):3332–40.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. Sharma S, Yang B, Strong R, Xi X, Brenneman M, Grotta JC, et al. Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res. 2010;88(13):2869–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Bedi SS, Walker PA, Shah SK, Jimenez F, Thomas CP, Smith P, et al. Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. J Trauma Acute Care Surg. 2013;75(3):410–6.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. Leal MM, Costa-Ferro ZS, Souza BS, Azevedo CM, Carvalho TM, Kaneto CM, et al. Early transplantation of bone marrow mononuclear cells promotes neuroprotection and modulation of inflammation after status epilepticus in mice by paracrine mechanisms. Neurochem Res. 2014;39(2):259–68.

    CAS  Article  PubMed  Google Scholar 

  19. Guo X, Bu X, Li Z, Yan Z, Jiang J, Zhou Z. Comparison of autologous bone marrow mononuclear cells transplantation and mobilization by granulocyte colony-stimulating factor in experimental spinal injury. Int J Neurosci. 2012;122(12):723–33.

    CAS  Article  PubMed  Google Scholar 

  20. Kanamaru T, Kamimura N, Yokota T, Nishimaki K, Iuchi K, Lee H, et al. Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer’s disease. Brain Res. 2015.

  21. Nakano-Doi A, Nakagomi T, Fujikawa M, Nakagomi N, Kubo S, Lu S, et al. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells (Dayton, Ohio). 2010;28(7):1292–302.

    CAS  Google Scholar 

  22. Prabhakar S, Muthaian R, Chabbra R, Anand A. Analysis of homing potential of marrow-derived mononuclear cells in an experimentally-induced brain stroke mouse model. Brain Inj. 2010;24(12):1485–90.

    Article  PubMed  Google Scholar 

  23. Zhou Z, Ma D. Anaesthetics-induced neurotoxicity in developing brain: an update on preclinical evidence. Brain Sci. 2014;4(1):136–49.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lin EP, Soriano SG, Loepke AW. Anesthetic neurotoxicity. Anesthesiol Clin. 2014;32(1):133–55.

    Article  PubMed  Google Scholar 

  25. Yang B, Migliati E, Parsha K, Schaar K, Xi X, Aronowski J, et al. Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke J Cereb Circ. 2013;44(12):3463–72.

    CAS  Article  Google Scholar 

  26. Boltze J, Nitzsche B, Geiger KD, Schoon HA. Histopathological investigation of different MCAO modalities and impact of autologous bone marrow mononuclear cell administration in an ovine stroke model. Transl Stroke Res. 2011;2(3):279–93.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Womble TA, Green S, Shahaduzzaman M, Grieco J, Sanberg PR, Pennypacker KR, et al. Monocytes are essential for the neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat. Mol Cell Neurosci. 2014;59:76–84.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. Patel AR, Ritzel R, McCullough LD, Liu F. Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol. 2013;5(2):73–90.

    PubMed  PubMed Central  Google Scholar 

  29. Kim JY, Kawabori M, Yenari MA. Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Curr Med Chem. 2014;21(18):2076–97.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

  1. Stroke Program, McGovern Medical School at UT-Health, 6431 Fannin Street, Houston, TX, 77030, USA

    Bing Yang, Kaushik Parsha, Krystal Schaar, XiaoPei Xi, Jaroslaw Aronowski & Sean I. Savitz

Authors
  1. Bing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaushik Parsha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krystal Schaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. XiaoPei Xi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jaroslaw Aronowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sean I. Savitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bing Yang.

Ethics declarations

Funding

This study was funded by NIH R-01 NS071127.

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All animal experiments and surgical procedures were approved by the University of Texas Health Science Center Animal Welfare Committee and followed NIH guidelines and regulations. This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, B., Parsha, K., Schaar, K. et al. Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke Model. Transl. Stroke Res. 7, 322–330 (2016). https://doi.org/10.1007/s12975-016-0462-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-016-0462-x

Keywords

  • Cellular therapy
  • Bone marrow
  • Mono-nuclear cells
  • Stroke